KemPharm Inc (NASDAQ:KMPH) has been given a consensus recommendation of “Buy” by the six ratings firms that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price […]
